Recent Finacing
Recent Raise
Cellectis is a French immunotherapy company that develops TALEN gene‑edited allogeneic CAR‑T therapies using the PulseAgile electroporation system, with programs like UCART19 and UCART123 and plant science applications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Cellectis.
